FINAL ELV DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Elevance Health, Inc. and Urgently Encourages Investors to Contact the Firm

Core Viewpoint - A class action lawsuit has been filed against Elevance Health, Inc. for allegedly making false or misleading statements regarding the impact of Medicaid redetermination on the company's financial guidance and cost trends [1][3]. Summary by Relevant Sections Lawsuit Details - The lawsuit is on behalf of all individuals and entities who purchased Elevance securities between April 18, 2024, and October 16, 2024, with a deadline for lead plaintiff applications set for July 11, 2025 [1]. - The defendants are accused of failing to disclose that the Medicaid redetermination process was leading to a significant rise in acuity and utilization of Medicaid members, contrary to their assurances to investors [3]. Financial Implications - Elevance's management claimed that premium rates negotiated with states were sufficient to manage the risks associated with Medicaid patients, despite rising Medicaid expenses [3]. - The lawsuit asserts that the financial guidance provided by Elevance did not accurately reflect the true impact of the redetermination process, leading to investor losses when the actual situation became known [3].